United States Biotechnology & Medical Research

Pharmacyclics Inc (PCYC)

Track

Track

Ticker: PCYC Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Soni Manmeet Singh Chief Financial Officer Officer
Transaction date
Sale
Price
317.37
Quantity 43,318 +4.1%
Value US$1,945,475
Soni Manmeet Singh Chief Financial Officer Officer
Transaction date
Sale
Price
331.23
Quantity 12,782 -32.3%
Value US$4,969,247
Tan Heow Chief Quality&Tech Operations Officer
Transaction date
Sale
Price
130.20
Quantity 12,219 -16.1%
Value US$585,304
Soni Manmeet Singh Chief Financial Officer Officer
Transaction date
Sale
Price
254.15
Quantity 24,098 -29.3%
Value US$6,124,507
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
254.11
Quantity 30,000 -11.8%
Value US$7,623,444
Fardis Maria Chief of Oncology Ops & Allian Officer
Transaction date
Sale
Price
141.30
Quantity 3,000 -48.4%
Value US$423,902
Soni Manmeet Singh Chief Financial Officer Officer
Transaction date
Sale
Price
141.44
Quantity 1,000 -2.5%
Value US$141,442
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
137.50
Quantity 658 -0.3%
Value US$90,475
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
138.01
Quantity 5,273 -2.4%
Value US$727,741
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
133.88
Quantity 6,476 -3.0%
Value US$866,997
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
133.76
Quantity 5,000 -2.3%
Value US$668,808
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
133.94
Quantity 8,524 -3.7%
Value US$1,141,722
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
133.50
Quantity 3,000 -1.3%
Value US$400,500
Love Richard B General Counsel Officer
Transaction date
Sale
Price
133.87
Quantity 1,500 -88.0%
Value US$200,805
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
135.01
Quantity 1,551 -0.7%
Value US$209,401
Fardis Maria Chief of Oncology Ops & Allian Officer
Transaction date
Sale
Price
134.50
Quantity 5,000 -61.0%
Value US$672,500
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
122.00
Quantity 5,000 -2.3%
Value US$610,000
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
121.10
Quantity 5,000 -2.3%
Value US$605,500
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
122.74
Quantity 2,000 -0.9%
Value US$245,480
Love Richard B General Counsel Officer
Transaction date
Sale
Price
124.00
Quantity 1,500 -88.0%
Value US$186,000
Fardis Maria Chief of Oncology Ops & Allian Officer
Transaction date
Sale
Price
121.01
Quantity 4,000 -55.6%
Value US$484,040
Tan Heow Chief Quality&Tech Operations Officer
Transaction date
Sale
Price
123.58
Quantity 10,000 -84.2%
Value US$1,235,808
McGreivy Jesse Chief Medical Officer Officer
Transaction date
Sale
Price
120.92
Quantity 34,062 -100.0%
Value US$4,118,610
Fardis Maria Chief of Oncology Ops & Allian Officer
Transaction date
Sale
Price
140.50
Quantity 3,000 -50.1%
Value US$421,504
McGreivy Jesse Chief Medical Officer Officer
Transaction date
Sale
Price
139.66
Quantity 6,563 -100.0%
Value US$916,599
Sjovall Boultbee Paula S EVP, Sales and Marketing Officer
Transaction date
Sale
Price
140.75
Quantity 6,253 -78.2%
Value US$880,115
Hemmi Gregory Sr. VP Chemical Operations Officer
Transaction date
Sale
Price
140.00
Quantity 15,000 -28.3%
Value US$2,100,033
HALVORSON ERIC H Non-Executive Director
Transaction date
Sale
Price
138.33
Quantity 3,472 -77.6%
Value US$480,282
Sjovall Boultbee Paula S EVP, Sales and Marketing Officer
Transaction date
Sale
Price
137.07
Quantity 13,747 -88.8%
Value US$1,884,330
Chang Betty Y VP, Research/Biology Officer
Transaction date
Sale
Price
137.97
Quantity 17,500 -82.3%
Value US$2,414,484
van den Broek Richard Non-Executive Director
Transaction date
Sale
Price
144.92
Quantity 25,000 -45.8%
Value US$3,622,990
van den Broek Richard Non-Executive Director
Transaction date
Sale
Price
147.13
Quantity 25,680 -32.0%
Value US$3,778,170
van den Broek Richard Non-Executive Director
Transaction date
Sale
Price
147.70
Quantity 28,155 -26.0%
Value US$4,158,496
Tan Heow Chief Quality&Tech Operations Officer
Transaction date
Sale
Price
100.78
Quantity 2,000 -92.2%
Value US$201,553
Tan Heow Chief Quality&Tech Operations Officer
Transaction date
Sale
Price
100.93
Quantity 3,000 -58.0%
Value US$302,799
Hemmi Gregory VP Chemical Operations Officer
Transaction date
Sale
Price
99.04
Quantity 10,000 -28.6%
Value US$990,380
Hemmi Gregory VP Chemical Operations Officer
Transaction date
Sale
Price
102.00
Quantity 10,000 -28.6%
Value US$1,020,000
Zanganeh Maky Chief Operating Officer Officer
Transaction date
Sale
Price
107.55
Quantity 20,000 -8.7%
Value US$2,151,000
Erdtmann Rainer M Sr. VP, IR and Admin Officer
Transaction date
Sale
Price
107.72
Quantity 22,835 -66.5%
Value US$2,459,681
Erdtmann Rainer M Sr. VP, IR and Admin Officer
Transaction date
Sale
Price
107.82
Quantity 31,165 -73.1%
Value US$3,360,114
Shearer Scott T VP, Global Quality Officer
Transaction date
Sale
Price
85.17
Quantity 18,750 -100.0%
Value US$1,596,994
Love Richard B VP and General Counsel Officer
Transaction date
Sale
Price
89.00
Quantity 8,000 -100.0%
Value US$712,000
Hemmi Gregory VP Chemical Operations Officer
Transaction date
Sale
Price
91.96
Quantity 50,000 -67.4%
Value US$4,598,115
McGreivy Jesse VP, Clinical Science Officer
Transaction date
Sale
Price
91.13
Quantity 14,479 -100.0%
Value US$1,319,510
Tan Heow Chief of Technical Operations Officer
Transaction date
Sale
Price
91.84
Quantity 5,237 -100.0%
Value US$480,961
Buggy Joseph J VP, Research Officer
Transaction date
Planned sale
Price
69.97
Quantity 12,000 -64.2%
Value US$839,666
Loury David J Chief Scientific Officer Officer
Transaction date
Planned sale
Price
70.58
Quantity 20,000 -98.4%
Value US$1,411,510
McGreivy Jesse VP, Clinical Science Officer
Transaction date
Sale
Price
67.29
Quantity 583 -100.0%
Value US$39,229
Hemmi Gregory VP Chemical Operations Officer
Transaction date
Sale
Price
67.11
Quantity 5,000 -17.9%
Value US$335,550
Loury David J Chief Scientific Officer Officer
Transaction date
Sale
Price
66.30
Quantity 10,531 -97.0%
Value US$698,205
Fardis Maria EVP, Operations and Alliances Officer
Transaction date
Sale
Price
65.00
Quantity 2,500 -71.9%
Value US$162,500
Loury David J Chief Scientific Officer Officer
Transaction date
Sale
Price
64.70
Quantity 10,000 -96.9%
Value US$647,000
Fardis Maria EVP, Operations and Alliances Officer
Transaction date
Sale
Price
64.20
Quantity 3,500 -50.2%
Value US$224,700
van den Broek Richard Non-Executive Director
Transaction date
Sale
Price
58.50
Quantity 7,171 -6.2%
Value US$419,476
van den Broek Richard Non-Executive Director
Transaction date
Sale
Price
57.98
Quantity 18,354 -14.5%
Value US$1,064,125
van den Broek Richard Non-Executive Director
Transaction date
Sale
Price
58.02
Quantity 11,931 -8.6%
Value US$692,239
Hemmi Gregory VP Chemical Operations Officer
Transaction date
Sale
Price
60.00
Quantity 2,625 -10.2%
Value US$157,500
Hemmi Gregory VP Chemical Operations Officer
Transaction date
Sale
Price
59.00
Quantity 10,275 -28.6%
Value US$606,225
Hemmi Gregory VP Chemical Operations Officer
Transaction date
Sale
Price
59.00
Quantity 100 -0.4%
Value US$5,900
Loury David J Chief Scientific Officer Officer
Transaction date
Sale
Price
61.12
Quantity 39,469 -99.2%
Value US$2,412,274
Erdtmann Rainer M VP, IR Education Training Officer
Transaction date
Sale
Price
62.41
Quantity 18,000 -39.6%
Value US$1,123,380
Erdtmann Rainer M VP, IR Education Training Officer
Transaction date
Sale
Price
62.51
Quantity 41,558 -47.7%
Value US$2,597,712
Erdtmann Rainer M VP, IR Education Training Officer
Transaction date
Sale
Price
62.73
Quantity 34,442 -55.6%
Value US$2,160,698
Buggy Joseph J VP, Research Officer
Transaction date
Sale
Price
62.14
Quantity 50,000 -88.2%
Value US$3,106,840
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 973 -100.0%
Value US$29,190
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 1,126 -100.0%
Value US$33,780
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 1,204 -100.0%
Value US$36,120
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 124 -100.0%
Value US$3,720
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 2,185 -100.0%
Value US$65,550
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 7,500 -100.0%
Value US$225,000
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 1,754 -100.0%
Value US$52,620
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 1,777 -100.0%
Value US$53,310
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
30.00
Quantity 1,922 -100.0%
Value US$57,660
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 1,935 -100.0%
Value US$48,375
Mehta Minesh Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 3,750 -100.0%
Value US$93,750
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-03-13 2015-03-13 S Sale Soni Manmeet Singh

Chief Financial Officer

Officer
43,318 +4.1%
317.37
US$1,945,475 		43,318 +4.1% 317.37 US$1,945,475
2015-03-13 2015-03-13 S Sale Soni Manmeet Singh

Chief Financial Officer

Officer
12,782 -32.3%
331.23
US$4,969,247 		12,782 -32.3% 331.23 US$4,969,247
2015-03-12 2015-03-12 S Sale Tan Heow

Chief Quality&Tech Operations

Officer
12,219 -16.1%
130.20
US$585,304 		12,219 -16.1% 130.20 US$585,304
2015-03-13 2015-03-11 S Sale Soni Manmeet Singh

Chief Financial Officer

Officer
24,098 -29.3%
254.15
US$6,124,507 		24,098 -29.3% 254.15 US$6,124,507
2015-03-13 2015-03-11 S Sale Zanganeh Maky

Chief Operating Officer

Officer
30,000 -11.8%
254.11
US$7,623,444 		30,000 -11.8% 254.11 US$7,623,444
2014-11-17 2014-11-13 S Sale Fardis Maria

Chief of Oncology Ops & Allian

Officer
3,000 -48.4%
141.30
US$423,902 		3,000 -48.4% 141.30 US$423,902
2014-11-17 2014-11-13 S Sale Soni Manmeet Singh

Chief Financial Officer

Officer
1,000 -2.5%
141.44
US$141,442 		1,000 -2.5% 141.44 US$141,442
2014-11-12 2014-11-12 S Sale Zanganeh Maky

Chief Operating Officer

Officer
658 -0.3%
137.50
US$90,475 		658 -0.3% 137.50 US$90,475
2014-11-12 2014-11-12 S Sale Zanganeh Maky

Chief Operating Officer

Officer
5,273 -2.4%
138.01
US$727,741 		5,273 -2.4% 138.01 US$727,741
2014-11-12 2014-11-10 S Sale Zanganeh Maky

Chief Operating Officer

Officer
6,476 -3.0%
133.88
US$866,997 		6,476 -3.0% 133.88 US$866,997
2014-11-12 2014-11-10 S Sale Zanganeh Maky

Chief Operating Officer

Officer
5,000 -2.3%
133.76
US$668,808 		5,000 -2.3% 133.76 US$668,808
2014-11-12 2014-11-10 S Sale Zanganeh Maky

Chief Operating Officer

Officer
8,524 -3.7%
133.94
US$1,141,722 		8,524 -3.7% 133.94 US$1,141,722
2014-11-12 2014-11-10 S Sale Zanganeh Maky

Chief Operating Officer

Officer
3,000 -1.3%
133.50
US$400,500 		3,000 -1.3% 133.50 US$400,500
2014-11-10 2014-11-10 S Sale Love Richard B

General Counsel

Officer
1,500 -88.0%
133.87
US$200,805 		1,500 -88.0% 133.87 US$200,805
2014-11-12 2014-11-07 S Sale Zanganeh Maky

Chief Operating Officer

Officer
1,551 -0.7%
135.01
US$209,401 		1,551 -0.7% 135.01 US$209,401
2014-11-10 2014-11-07 S Sale Fardis Maria

Chief of Oncology Ops & Allian

Officer
5,000 -61.0%
134.50
US$672,500 		5,000 -61.0% 134.50 US$672,500
2014-09-04 2014-09-04 S Sale Zanganeh Maky

Chief Operating Officer

Officer
5,000 -2.3%
122.00
US$610,000 		5,000 -2.3% 122.00 US$610,000
2014-09-04 2014-09-03 S Sale Zanganeh Maky

Chief Operating Officer

Officer
5,000 -2.3%
121.10
US$605,500 		5,000 -2.3% 121.10 US$605,500
2014-09-04 2014-09-03 S Sale Zanganeh Maky

Chief Operating Officer

Officer
2,000 -0.9%
122.74
US$245,480 		2,000 -0.9% 122.74 US$245,480
2014-08-28 2014-08-27 S Sale Love Richard B

General Counsel

Officer
1,500 -88.0%
124.00
US$186,000 		1,500 -88.0% 124.00 US$186,000
2014-08-15 2014-08-13 S Sale Fardis Maria

Chief of Oncology Ops & Allian

Officer
4,000 -55.6%
121.01
US$484,040 		4,000 -55.6% 121.01 US$484,040
2014-08-13 2014-08-13 S Sale Tan Heow

Chief Quality&Tech Operations

Officer
10,000 -84.2%
123.58
US$1,235,808 		10,000 -84.2% 123.58 US$1,235,808
2014-08-07 2014-08-07 S Sale McGreivy Jesse

Chief Medical Officer

Officer
34,062 -100.0%
120.92
US$4,118,610 		34,062 -100.0% 120.92 US$4,118,610
2014-03-07 2014-03-05 S Sale Fardis Maria

Chief of Oncology Ops & Allian

Officer
3,000 -50.1%
140.50
US$421,504 		3,000 -50.1% 140.50 US$421,504
2014-03-06 2014-03-05 S Sale McGreivy Jesse

Chief Medical Officer

Officer
6,563 -100.0%
139.66
US$916,599 		6,563 -100.0% 139.66 US$916,599
2014-03-06 2014-03-05 S Sale Sjovall Boultbee Paula S

EVP, Sales and Marketing

Officer
6,253 -78.2%
140.75
US$880,115 		6,253 -78.2% 140.75 US$880,115
2014-03-06 2014-03-05 S Sale Hemmi Gregory

Sr. VP Chemical Operations

Officer
15,000 -28.3%
140.00
US$2,100,033 		15,000 -28.3% 140.00 US$2,100,033
2014-03-06 2014-03-04 S Sale HALVORSON ERIC H Non-Executive Director
3,472 -77.6%
138.33
US$480,282 		3,472 -77.6% 138.33 US$480,282
2014-03-06 2014-03-04 S Sale Sjovall Boultbee Paula S

EVP, Sales and Marketing

Officer
13,747 -88.8%
137.07
US$1,884,330 		13,747 -88.8% 137.07 US$1,884,330
2014-03-05 2014-03-04 S Sale Chang Betty Y

VP, Research/Biology

Officer
17,500 -82.3%
137.97
US$2,414,484 		17,500 -82.3% 137.97 US$2,414,484
2014-02-28 2014-02-27 S Sale van den Broek Richard Non-Executive Director
25,000 -45.8%
144.92
US$3,622,990 		25,000 -45.8% 144.92 US$3,622,990
2014-02-28 2014-02-26 S Sale van den Broek Richard Non-Executive Director
25,680 -32.0%
147.13
US$3,778,170 		25,680 -32.0% 147.13 US$3,778,170
2014-02-28 2014-02-25 S Sale van den Broek Richard Non-Executive Director
28,155 -26.0%
147.70
US$4,158,496 		28,155 -26.0% 147.70 US$4,158,496
2013-12-20 2013-12-19 S Sale Tan Heow

Chief Quality&Tech Operations

Officer
2,000 -92.2%
100.78
US$201,553 		2,000 -92.2% 100.78 US$201,553
2013-12-20 2013-12-19 S Sale Tan Heow

Chief Quality&Tech Operations

Officer
3,000 -58.0%
100.93
US$302,799 		3,000 -58.0% 100.93 US$302,799
2013-12-18 2013-12-18 S Sale Hemmi Gregory

VP Chemical Operations

Officer
10,000 -28.6%
99.04
US$990,380 		10,000 -28.6% 99.04 US$990,380
2013-12-18 2013-12-17 S Sale Hemmi Gregory

VP Chemical Operations

Officer
10,000 -28.6%
102.00
US$1,020,000 		10,000 -28.6% 102.00 US$1,020,000
2013-12-18 2013-12-16 S Sale Zanganeh Maky

Chief Operating Officer

Officer
20,000 -8.7%
107.55
US$2,151,000 		20,000 -8.7% 107.55 US$2,151,000
2013-12-16 2013-12-16 S Sale Erdtmann Rainer M

Sr. VP, IR and Admin

Officer
22,835 -66.5%
107.72
US$2,459,681 		22,835 -66.5% 107.72 US$2,459,681
2013-12-16 2013-12-13 S Sale Erdtmann Rainer M

Sr. VP, IR and Admin

Officer
31,165 -73.1%
107.82
US$3,360,114 		31,165 -73.1% 107.82 US$3,360,114
2013-06-06 2013-06-06 S Sale Shearer Scott T

VP, Global Quality

Officer
18,750 -100.0%
85.17
US$1,596,994 		18,750 -100.0% 85.17 US$1,596,994
2013-05-31 2013-05-31 S Sale Love Richard B

VP and General Counsel

Officer
8,000 -100.0%
89.00
US$712,000 		8,000 -100.0% 89.00 US$712,000
2013-05-31 2013-05-31 S Sale Hemmi Gregory

VP Chemical Operations

Officer
50,000 -67.4%
91.96
US$4,598,115 		50,000 -67.4% 91.96 US$4,598,115
2013-05-31 2013-05-31 S Sale McGreivy Jesse

VP, Clinical Science

Officer
14,479 -100.0%
91.13
US$1,319,510 		14,479 -100.0% 91.13 US$1,319,510
2013-05-31 2013-05-31 S Sale Tan Heow

Chief of Technical Operations

Officer
5,237 -100.0%
91.84
US$480,961 		5,237 -100.0% 91.84 US$480,961
2013-02-11 2013-02-11 PlS Planned sale Buggy Joseph J

VP, Research

Officer
12,000 -64.2%
69.97
US$839,666 		12,000 -64.2% 69.97 US$839,666
2013-02-05 2013-02-05 PlS Planned sale Loury David J

Chief Scientific Officer

Officer
20,000 -98.4%
70.58
US$1,411,510 		20,000 -98.4% 70.58 US$1,411,510
2013-01-18 2013-01-17 S Sale McGreivy Jesse

VP, Clinical Science

Officer
583 -100.0%
67.29
US$39,229 		583 -100.0% 67.29 US$39,229
2013-01-11 2013-01-11 S Sale Hemmi Gregory

VP Chemical Operations

Officer
5,000 -17.9%
67.11
US$335,550 		5,000 -17.9% 67.11 US$335,550
2013-01-10 2013-01-09 S Sale Loury David J

Chief Scientific Officer

Officer
10,531 -97.0%
66.30
US$698,205 		10,531 -97.0% 66.30 US$698,205
2013-01-09 2013-01-08 S Sale Fardis Maria

EVP, Operations and Alliances

Officer
2,500 -71.9%
65.00
US$162,500 		2,500 -71.9% 65.00 US$162,500
2013-01-08 2013-01-08 S Sale Loury David J

Chief Scientific Officer

Officer
10,000 -96.9%
64.70
US$647,000 		10,000 -96.9% 64.70 US$647,000
2013-01-07 2013-01-07 S Sale Fardis Maria

EVP, Operations and Alliances

Officer
3,500 -50.2%
64.20
US$224,700 		3,500 -50.2% 64.20 US$224,700
2013-01-02 2012-12-31 S Sale van den Broek Richard Non-Executive Director
7,171 -6.2%
58.50
US$419,476 		7,171 -6.2% 58.50 US$419,476
2012-12-28 2012-12-28 S Sale van den Broek Richard Non-Executive Director
18,354 -14.5%
57.98
US$1,064,125 		18,354 -14.5% 57.98 US$1,064,125
2012-12-28 2012-12-27 S Sale van den Broek Richard Non-Executive Director
11,931 -8.6%
58.02
US$692,239 		11,931 -8.6% 58.02 US$692,239
2012-12-27 2012-12-27 S Sale Hemmi Gregory

VP Chemical Operations

Officer
2,625 -10.2%
60.00
US$157,500 		2,625 -10.2% 60.00 US$157,500
2012-12-27 2012-12-27 S Sale Hemmi Gregory

VP Chemical Operations

Officer
10,275 -28.6%
59.00
US$606,225 		10,275 -28.6% 59.00 US$606,225
2012-12-27 2012-12-26 S Sale Hemmi Gregory

VP Chemical Operations

Officer
100 -0.4%
59.00
US$5,900 		100 -0.4% 59.00 US$5,900
2012-12-21 2012-12-20 S Sale Loury David J

Chief Scientific Officer

Officer
39,469 -99.2%
61.12
US$2,412,274 		39,469 -99.2% 61.12 US$2,412,274
2012-12-18 2012-12-18 S Sale Erdtmann Rainer M

VP, IR Education Training

Officer
18,000 -39.6%
62.41
US$1,123,380 		18,000 -39.6% 62.41 US$1,123,380
2012-12-18 2012-12-18 S Sale Erdtmann Rainer M

VP, IR Education Training

Officer
41,558 -47.7%
62.51
US$2,597,712 		41,558 -47.7% 62.51 US$2,597,712
2012-12-18 2012-12-17 S Sale Erdtmann Rainer M

VP, IR Education Training

Officer
34,442 -55.6%
62.73
US$2,160,698 		34,442 -55.6% 62.73 US$2,160,698
2012-12-17 2012-12-17 S Sale Buggy Joseph J

VP, Research

Officer
50,000 -88.2%
62.14
US$3,106,840 		50,000 -88.2% 62.14 US$3,106,840
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
973 -100.0%
30.00
US$29,190 		973 -100.0% 30.00 US$29,190
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,126 -100.0%
30.00
US$33,780 		1,126 -100.0% 30.00 US$33,780
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,204 -100.0%
30.00
US$36,120 		1,204 -100.0% 30.00 US$36,120
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
124 -100.0%
30.00
US$3,720 		124 -100.0% 30.00 US$3,720
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
2,185 -100.0%
30.00
US$65,550 		2,185 -100.0% 30.00 US$65,550
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
7,500 -100.0%
30.00
US$225,000 		7,500 -100.0% 30.00 US$225,000
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,754 -100.0%
30.00
US$52,620 		1,754 -100.0% 30.00 US$52,620
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,777 -100.0%
30.00
US$53,310 		1,777 -100.0% 30.00 US$53,310
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,922 -100.0%
30.00
US$57,660 		1,922 -100.0% 30.00 US$57,660
2012-02-15 2012-02-13 PlS Planned sale Mehta Minesh Non-Executive Director
1,935 -100.0%
25.00
US$48,375 		1,935 -100.0% 25.00 US$48,375
2012-02-15 2012-02-13 PlS Planned sale Mehta Minesh Non-Executive Director
3,750 -100.0%
25.00
US$93,750 		3,750 -100.0% 25.00 US$93,750
Explore more

More insider trading research around Pharmacyclics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America